everyone name operator today time would like welcome everyone danaher corporation third quarter earn result conference call operator instruction would like turn call vice president investor relation please ahead vice president investor relation good morning everyone thank join call today president chief executive officer executive vice president chief financial officer director investor relation like point earn release slide presentation supplement today call reconciliation information require regulation relate financial measure provide call available investor section website danaher head quarterly earn audio portion call archive investor section website later today head event presentation remain archive next quarterly call replay call also available presentation describe certain significant factor impact year year performance supplemental material describe additional factor impact year year performance unless otherwise note reference remark supplemental material company specific financial metric refer result continue operation relate third quarter reference period period increase decrease financial metric year year also describe certain product device application submit pending certain regulatory approval available certain market call make forward look statement within mean federal security include statement regard event development believe anticipate occur future forward look statement subject number risk uncertainty include forth file actual result might differ materially forward look statement make today forward look statement speak date make assume obligation update forward look statement except require result size acquisition impact danaher overall core revenue growth profile present core revenue basis include sale reference core revenue growth include sale calculation period period sale growth like turn call president chief executive thank good morning everyone really appreciate join call today deliver another outstanding result third quarter core revenue growth nearly adjust earn share growth strong free cash flow generation round performance testament unique position portfolio exceptional commit lead execute danaher business system every like thank join last month virtual investor opportunity showcase strong foundation build generate sustainable long term outperformance highlight fantastic portfolio market lead franchise highly attractive market exceptional field every differentiate danaher business system certainly powerful combination action third quarter result attest also talk sustainability effort last week publish sustainability report year report reflect measurable progress make across three pillar sustainability program innovation people environment danaher business system execute increasingly important strategic priority hope chance read report learn important work across danaher positively impact world around generation come turn third quarter result sale billion deliver core revenue growth portfoliowide strength lead diagnostics life science geographically high growth market grow approximately develop market nearly fact revenue three largest market north western approximately quarter gross profit margin increase basis point primarily higher sale volume favorable impact higher margin product impact prior year purchase account adjustment relate acquisition repeat adjust dilute earn common share compare generate billion free cash flow quarter bring year date total billion year year continue accelerate organic growth investment across entire portfolio increase research development spend approximately year year investor recently highlight growth tool process accelerate innovation bring impactful solution customer faster fact recently launch product like triple quad life science benchtop cell sorter great example drive market share gain proprietary innovation enhance growth trajectory forward also make substantial investment expand production capacity across bioprocessing business near term investment support exist customer demand drive meaningful share gain equally important support long term growth business significant runway ahead give underlie structural growth driver sector serve expect total capital expenditure across danaher approximately billion continue invest support customer need today future detail quarterly result across segment life science report revenue increase core revenue growth broad base across segment major operate company achieve high teen better core growth strong result lead continue demand bioprocessing solution bioprocessing biotech grow quarter include double digit relate core growth relate vaccine therapeutic revenue contribute continue strong exceed billion year date pass important milestone last month exit last transition service agreement successfully complete process ahead schedule testament entire integration collective commitment danaher business system also associate global since join danaher help ensure support customer today continue meet need future successfully close acquisition thrill officially welcome danaher lead producer high quality plasmid protein provide fantastic beachhead genomic medicine enterprise rapid development gene cell therapy vaccine gene edit technology expand capability area ultimately help customer bring life save therapy vaccine market faster really excite quality scale turnaround time reputation bring danaher portfolio diagnostics report revenue core revenue grow lead growth major diagnostic business grow teen quarter clinical diagnostic activity patient volume around world largely return pandemic level respiratory test expand manufacture capacity enable produce ship approximately million cartridge quarter test account approximately shipment combination test represent approximately respiratory core growth double digit lead demand hospital acquire infection sexual health virology test also strong growth base system placement continue exceed pandemic rate believe thoughtful placement infinity system last month future growth opportunity move environmental apply solution segment report revenue core revenue water quality grow single digit product identification platform double digit across water quality business good underlie market strength particularly food beverage various industrial application activity return normal level municipal project pick give improve fund environment customer return person work product identification package color management business double digit quarter comparable strength across consumables service base growth drive normalize level customer activity investment believe ability meet customer need particularly equipment side enable gain market share expand industry lead base printer backdrop quarter spend time regional market trend major region country around world largely back pandemic activity level customer adapt current operate environment protocol broadly resume person commercial activity site access reflect strong result across momentum also reflect strong order book growth trend revenue growth mindful potential variant outbreak selective lockdown currently material negative impact scenario global supply chain constraint leverage danaher business system tool like daily management actively work customer supplier help mitigate impact across life science robust customer activity demand across major market site access largely back level normalize productivity level installation project initiation drive strong fund environment biopharma continue lead number life save biologic genomic base therapy development production continue rise augment ongoing work around vaccine therapeutic recent investor spend time cover position support complex life change work customer pursue combine bioprocessing portfolio across biotech broadest offer industry lead position upstream downstream application support customer best class scientific service partner solve challenge problem move production scale global reach enable reliably consistently meet customer need addition industrywide opportunity biologics genomic base medicine continue significant demand relate development production vaccine therapeutic customer work address emerge variant increase global supply give third global population vaccinate believe durable growth biopharma segment foreseeable future continue expect billion relate vaccine therapeutic revenue since speak investor expect enter approximately billion relate backlog versus previous expectation billion backlog increase drive recent enhance visibility booster likelihood vaccine availability child year move clinical diagnostic market test volume essentially back pandemic level major region patient return wellness check routine screen elective procedure molecular diagnostics strong global demand persist point care respiratory test result delta variant outbreak along lower vaccine vaccination rate many region mention earlier ship approximately million respiratory test third quarter expect ship approximately million test versus prior expectation million head traditional respiratory virus season hear customer expect much active season last year preparation preference combination test uptick demand cartridge particularly give recent outbreak across test also recently approve third gene target detection ensure continue accurately detect future viral mutation reinforce competitive advantage respiratory test market move apply market customer activity largely rebound pandemic level robust order rate across consumables equipment global municipal market consumables demand remain solid pace instrument orient project activity continue pick improve fund environment broad return work look ahead expectation fourth quarter full year expect deliver fourth quarter core revenue growth teen range high single digit core revenue growth base business high single digit core growth contribution relate revenue tailwind additionally expect generate operate profit fall approximately fourth quarter similar level achieve third quarter full year expect deliver core tailwind base business contribute core revenue growth rate wrap proud deliver another terrific result third quarter performance testament power unique portfolio strength market commitment lead execute danaher business system unique combination differentiate danaher today reinforce opportunity ahead sustainable long term outperformance back vice president investor relation conclude formal comment ready take question